Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis

SU Khan, M Osman, MU Khan, MS Khan… - Annals of internal …, 2020 - acpjournals.org
Background: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …
被引用次数：47 相关文章

[引用][C] Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention

SU Khan, M Osman, MU Khan, MS Khan… - Annals of Internal …, 2020 - cir.nii.ac.jp
Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF] researchgate.net

[PDF][PDF] Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention

SU Khan, M Osman, MU Khan, MS Khan, D Zhao… - Ann Intern …, 2020 - researchgate.net
Background: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …

Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention a systematic review and meta-analysis

SU Khan, M Osman, MU Khan… - Annals of internal …, 2020 - pure.johnshopkins.edu
Background: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …

Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

SU Khan, M Osman, MU Khan… - Annals of internal …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …

Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.

SU Khan, M Osman, MU Khan, MS Khan… - Annals of Internal …, 2020 - europepmc.org
Background The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …
[HTML] nih.gov

[HTML][HTML] Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

SU Khan, M Osman, MU Khan, MS Khan… - Annals of internal …, 2020 - ncbi.nlm.nih.gov
Background The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …